美国感染病学会2019战略计划的制定、目标与举措
该计划提出四项关键举措:优化感染病指南的制定与采纳、量化并倡导感染病医师的价值、促进感染病人才队伍发展、开发衡量抗菌药物耐药进展的美国基准工具。
要点
- IDSA 2019战略计划包含四项关键举措。
- 举措涉及指南优化、医师价值倡导、人才培养和抗菌药物耐药基准。
- 董事会将与志愿者、合作伙伴和员工共同推进计划。
核心结论
- IDSA 2019战略计划提出四项关键举措以指导学会未来工作。
主要发现
- 2019年IDSA战略计划包含四项关键举措:优化感染病指南的制定、传播和采纳;量化、沟通并倡导感染病医师的价值;促进感染病人才队伍的成长与发展;开发并定位一个用于衡量和推动美国抗菌药物耐药进展的新工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In October 2018, the Infectious Diseases Society of America (IDSA) Board of Directors (BOD) decided to develop a 2019 IDSA Strategic Plan. The IDSA BOD has invested in strategic planning at regular intervals as part of an ongoing process to review and to renew the vision and direction of IDSA. Herein, the 2018-2019 strategic planning process and outcomes are described. The 2019 IDSA Strategic Plan presents 4 key initiatives: (1) optimize the development, dissemination, and adoption of timely and relevant ID guidance and guidelines that improve the outcomes of clinical care; (2) quantify, communicate, and advocate for the value of ID physicians to increase professional fulfillment and compensation; (3) facilitate the growth and development of the ID workforce to meet emerging scientific, clinical, and leadership needs; and (4) develop and position a new tool to serve as the leading US benchmark to measure and drive national progress on antimicrobial resistance. The BOD looks forward to developing, implementing, assessing, and advancing the 2019 IDSA Strategic Plan working with member volunteers, Society partners, and IDSA staff.
引用
- Sears CL, File TM, Alexander BD, et al. Charting the Path Forward: Development, Goals and Initiatives of the 2019 Infectious Diseases Society of America Strategic Plan. Clin Infect Dis. 2019. PMID: 31620782. doi:10.1093/cid/ciz1040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。